Boston

This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.

This trial is looking at improving treatment for bowel cancer. It’s for people who have locally advanced bowel cancer with a gene change called BRAFV600E.

This trial is looking at bone marrow samples to help work out the best treatment for myeloma.

This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.

This trial is looking at chemotherapy before surgery for bowel cancer to improve treatment.

This trial is looking at a drug called abemaciclib for women whose hormone therapy might not work so well.

This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older.

This trial is for people who might not be able to have the full dose of treatment because they have other illnesses or are not fit enough.

This study is for people with follicular lymphoma who are going to have treatment that reaches their whole body (systemic treatment) for the first time.

This trial is to see if adding radiotherapy to the lymph nodes in the pelvis to radiotherapy to the prostate, improves treatment for prostate cancer.